PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION. Wor.Bul.Pub.Helt. 2026;56:82-84. Accessed June 4, 2026. https://scholarexpress.net/index.php/wbph/article/view/5983